DE3482306D1 - Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten. - Google Patents

Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten.

Info

Publication number: DE3482306D1
Authority: DE; Germany
Prior art keywords: plasma; filled; plasma derivatives; available plasma; containers
Prior art date: 1983-03-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE8484890049T

Other languages

English (en)

Inventor

Anton Philapitsch

Yendra Dr Linnau

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Oesterreichisches Institut fuer Haemoderivate

Original Assignee

Immuno AG

Immuno AG fuer Chemisch Medizinische Produkte

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-03-16

Filing date

1984-03-15

Publication date

1990-06-28

1984-03-15 Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG

1990-06-28 Application granted granted Critical

1990-06-28 Publication of DE3482306D1 publication Critical patent/DE3482306D1/de

2004-03-16 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

DE8484890049T 1983-03-16 1984-03-15 Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten. Expired - Lifetime DE3482306D1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT0093283A AT376367B (de)	1983-03-16	1983-03-16	Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten

Publications (1)

Publication Number	Publication Date
DE3482306D1 true DE3482306D1 (de)	1990-06-28

Family

ID=3503162

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8484890049T Expired - Lifetime DE3482306D1 (de)	1983-03-16	1984-03-15	Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten.

Country Status (7)

Country	Link
US (1)	US4608254A (de)
EP (1)	EP0119990B1 (de)
JP (1)	JPS59181221A (de)
AT (2)	AT376367B (de)
CA (1)	CA1205012A (de)
DE (1)	DE3482306D1 (de)
ES (1)	ES8507347A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK475386D0 (da)	1986-10-03	1986-10-03	Weis Fogh Ulla Sivertsen	Fremgangsmaade og apparat til fremstilling af biologiske stoffer
AT391810B (de) *	1988-02-26	1990-12-10	Immuno Ag	Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
US5420250A (en) *	1990-08-06	1995-05-30	Fibrin Corporation	Phase transfer process for producing native plasma protein concentrates
US5644032A (en) *	1990-08-06	1997-07-01	Fibrin Corporation	Process for producing fibrinogen concentrates
MXPA05005328A (es) *	2002-11-25	2005-08-16	Octapharma Ag	Fraccion de albumina derivada de plasma con precalicreina empobrecida.
EP2522755B1 (de)	2007-08-13	2014-04-02	Baxter International Inc.	IVIg-Modulation von Chemokinen zur Behandlung von Multipler Sklerose, Morbus Alzheimer und Morbus Parkinson
EP2197487B1 (de) *	2007-09-04	2016-01-06	The Government of The United States of America, as represented by the Secretary, Department of Health and Human Services,	Thermische rotavirus-inaktivierung
IL274512B1 (en)	2012-02-29	2024-03-01	Baxalta Inc	IgG-stimulated remodeling of peripheral nerve myelin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2460137A1 (fr) *	1979-06-29	1981-01-23	Merieux Inst	Nouveau medicament a base d'alpha2-macroglobuline, sa preparation et son application
US4379085A (en) *	1982-05-14	1983-04-05	American National Red Cross	Heat stabilization of plasma proteins
DE3228502A1 (de) *	1982-07-30	1984-02-02	Behringwerke Ag, 3550 Marburg	Verfahren zur herstellung des c1-inaktivators und seine verwendung

1983
- 1983-03-16 AT AT0093283A patent/AT376367B/de not_active IP Right Cessation
1984
- 1984-02-28 CA CA000448394A patent/CA1205012A/en not_active Expired
- 1984-03-07 US US06/587,223 patent/US4608254A/en not_active Expired - Lifetime
- 1984-03-09 ES ES530488A patent/ES8507347A1/es not_active Expired
- 1984-03-14 JP JP59050128A patent/JPS59181221A/ja active Pending
- 1984-03-15 AT AT84890049T patent/ATE52919T1/de not_active IP Right Cessation
- 1984-03-15 DE DE8484890049T patent/DE3482306D1/de not_active Expired - Lifetime
- 1984-03-15 EP EP84890049A patent/EP0119990B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0119990A2 (de)	1984-09-26
EP0119990B1 (de)	1990-05-23
ATA93283A (de)	1984-04-15
JPS59181221A (ja)	1984-10-15
ES530488A0 (es)	1985-09-01
US4608254A (en)	1986-08-26
ES8507347A1 (es)	1985-09-01
ATE52919T1 (de)	1990-06-15
AT376367B (de)	1984-11-12
EP0119990A3 (en)	1987-07-01
CA1205012A (en)	1986-05-27

Similar Documents

Publication	Publication Date	Title
DE58900776D1 (de)	1992-03-12	Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
IT1132101B (it)	1986-06-25	Procedimento per la produzione di etanolo in forte concentrazione impiegando microorganismi immobilizzati
DE69530242D1 (de)	2003-05-15	Verfahren zur Herstellung von Glutaminsäure durch Fermentation
SE8204400D0 (sv)	1982-07-20	Forfaringssett for framstellning av porosa cellulosaperlor
DE3482306D1 (de)	1990-06-28	Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten.
ATE1217T1 (de)	1982-07-15	Verfahren zur isolierung von hbsag.
GB1488774A (en)	1977-10-12	Hepatitis b antigen and method of producing it
DE69011880D1 (de)	1994-10-06	Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
DE68908576T2 (de)	1993-12-23	Verfahren zur Herstellung von Aktivkohle.
DE68914236D1 (de)	1994-05-05	Verfahren zur Herstellung von Natriumhyaluronat durch Gärung.
DE3865777D1 (de)	1991-11-28	Verfahren zur reinigung von olivenoel.
DE3485823D1 (de)	1992-08-27	Verfahren zur herstellung von l-tryptophan durch gaerung.
ATE20737T1 (de)	1986-08-15	Verfahren zur herstellung von acemetacin.
DE68923534T2 (de)	1996-01-04	Verfahren zur Herstellung eines organischen Kristalls.
DE69218700D1 (de)	1997-05-07	Verfahren zur Herstellung von Riboflavin durch Fermentation
DE69005168T2 (de)	1994-06-30	Verfahren zur Herstellung von langen Rohren mit kleinem Durchmesser.
AT391810B (de)	1990-12-10	Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
DD127742A5 (de)	1977-10-12	Verfahren zur herstellung von substituierten n-methylenderivaten von thienamycin
ATE9871T1 (de)	1984-11-15	Amoxicillinsolvat, verfahren zur herstellung und verfahren zur herstellung von dieses solvat enthaltenden injizierbaren praeparaten.
AT334857B (de)	1977-02-10	Verfahren zur alkoholischen vergarung von zuckerhaltigen substraten
CH541623A (de)	1973-09-15	Mikrobiologisches Verfahren zur Herstellung von hochwertigem Protein
AT383827B (de)	1987-08-25	Verfahren zur kontinuierlichen herstellung von gaerungsalkohol
PT79232B (en)	1986-11-18	Process for producing immune interferon and of pharmaceutical compositions containing the same
DE3887070T2 (de)	1994-07-07	Verfahren zur Herstellung von Brenztraubensäure durch Fermentation.
ATE31245T1 (de)	1987-12-15	Verfahren zur stabilisierung von haematin.

Legal Events

Date	Code	Title	Description
1991-06-20	8364	No opposition during term of opposition
2003-01-16	8339	Ceased/non-payment of the annual fee